| J0120 | Injection, tetracycline, up to 250 mg |
| J0121 | Injection, omadacycline, 1 mg |
| J0122 | Injection, eravacycline, 1 mg |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| J0130 | Injection abciximab, 10 mg |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg |
| J0132 | Injection, acetylcysteine, 100 mg |
| J0133 | Injection, acyclovir, 5 mg |
| J0134 | Injection, acetaminophen (fresenius kabi) not therapeutically equivalent to j0131, 10 mg |
| J0135 | Injection, adalimumab, 20 mg |
| J0136 | Injection, acetaminophen (b braun) not therapeutically equivalent to j0131, 10 mg |
| J0137 | Injection, acetaminophen (hikma) not therapeutically equivalent to j0131, 10 mg |
| J0150 | Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) |
| J0151 | Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg |
| J0172 | Injection, aducanumab-avwa, 2 mg |
| J0173 | Injection, epinephrine (belcher) not therapeutically equivalent to j0171, 0.1 mg |
| J0174 | Injection, lecanemab-irmb, 1 mg |
| J0178 | Injection, aflibercept, 1 mg |
| J0179 | Injection, brolucizumab-dbll, 1 mg |
| J0180 | Injection, agalsidase beta, 1 mg |
| J0185 | Injection, aprepitant, 1 mg |
| J0190 | Injection, biperiden lactate, per 5 mg |
| J0200 | Injection, alatrofloxacin mesylate, 100 mg |
| J0202 | Injection, alemtuzumab, 1 mg |
| J0205 | Injection, alglucerase, per 10 units |
| J0206 | Injection, allopurinol sodium, 1 mg |
| J0207 | Injection, amifostine, 500 mg |
| J0208 | Injection, sodium thiosulfate, 100 mg |
| J0210 | Injection, methyldopate hcl, up to 250 mg |
| J0215 | Injection, alefacept, 0.5 mg |
| J0216 | Injection, alfentanil hydrochloride, 500 micrograms |
| J0218 | Injection, olipudase alfa-rpcp, 1 mg |
| J0219 | Injection, avalglucosidase alfa-ngpt, 4 mg |
| J0220 | Injection, alglucosidase alfa, 10 mg, not otherwise specified |
| J0221 | Injection, alglucosidase alfa, (lumizyme), 10 mg |
| J0222 | Injection, patisiran, 0.1 mg |
| J0223 | Injection, givosiran, 0.5 mg |
| J0224 | Injection, lumasiran, 0.5 mg |
| J0225 | Injection, vutrisiran, 1 mg |
| J0248 | Injection, remdesivir, 1 mg |
| J0256 | Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg |
| J0257 | Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg |
| J0270 | Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| J0275 | Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| J0278 | Injection, amikacin sulfate, 100 mg |
| J0280 | Injection, aminophyllin, up to 250 mg |
| J0282 | Injection, amiodarone hydrochloride, 30 mg |
| J0283 | Injection, amiodarone hydrochloride (nexterone), 30 mg |
| J0285 | Injection, amphotericin b, 50 mg |
| J0287 | Injection, amphotericin b lipid complex, 10 mg |
| J0288 | Injection, amphotericin b cholesteryl sulfate complex, 10 mg |
| J0289 | Injection, amphotericin b liposome, 10 mg |
| J0290 | Injection, ampicillin sodium, 500 mg |
| J0291 | Injection, plazomicin, 5 mg |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
| J0300 | Injection, amobarbital, up to 125 mg |
| J0330 | Injection, succinylcholine chloride, up to 20 mg |
| J0348 | Injection, anidulafungin, 1 mg |
| J0350 | Injection, anistreplase, per 30 units |
| J0360 | Injection, hydralazine hcl, up to 20 mg |
| J0364 | Injection, apomorphine hydrochloride, 1 mg |
| J0365 | Injection, aprotonin, 10,000 kiu |
| J0380 | Injection, metaraminol bitartrate, per 10 mg |
| J0390 | Injection, chloroquine hydrochloride, up to 250 mg |
| J0395 | Injection, arbutamine hcl, 1 mg |
| J0400 | Injection, aripiprazole, intramuscular, 0.25 mg |
| J0401 | Injection, aripiprazole, extended release, 1 mg |
| J0456 | Injection, azithromycin, 500 mg |
| J0457 | Injection, aztreonam, 100 mg |
| J0461 | Injection, atropine sulfate, 0.01 mg |
| J0470 | Injection, dimercaprol, per 100 mg |
| J0475 | Injection, baclofen, 10 mg |
| J0476 | Injection, baclofen, 50 mcg for intrathecal trial |
| J0480 | Injection, basiliximab, 20 mg |
| J0485 | Injection, belatacept, 1 mg |
| J0490 | Injection, belimumab, 10 mg |
| J0491 | Injection, anifrolumab-fnia, 1 mg |
| J0500 | Injection, dicyclomine hcl, up to 20 mg |
| J0515 | Injection, benztropine mesylate, per 1 mg |
| J0517 | Injection, benralizumab, 1 mg |
| J0520 | Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg |
| J0558 | Injection, penicillin g benzathine and penicillin g procaine, 100,000 units |
| J0561 | Injection, penicillin g benzathine, 100,000 units |
| J0565 | Injection, bezlotoxumab, 10 mg |
| J0567 | Injection, cerliponase alfa, 1 mg |
| J0570 | Buprenorphine implant, 74.2 mg |
| J0571 | Buprenorphine, oral, 1 mg |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine |
| J0573 | Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine |
| J0575 | Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine |
| J0583 | Injection, bivalirudin, 1 mg |
| J0584 | Injection, burosumab-twza 1 mg |
| J0585 | Injection, onabotulinumtoxina, 1 unit |
| J0586 | Injection, abobotulinumtoxina, 5 units |
| J0587 | Injection, rimabotulinumtoxinb, 100 units |
| J0588 | Injection, incobotulinumtoxin a, 1 unit |
| J0591 | Injection, deoxycholic acid, 1 mg |
| J0592 | Injection, buprenorphine hydrochloride, 0.1 mg |
| J0593 | Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered) |
| J0594 | injection, busulfan, 1 mg |
| J9293 | Injection, mitoxantrone hydrochloride, per 5 mg |
| J9294 | Injection, pemetrexed (hospira) not therapeutically equivalent to j9305, 10 mg |
| J9295 | Injection, necitumumab, 1 mg |
| J9296 | Injection, pemetrexed (accord) not therapeutically equivalent to j9305, 10 mg |
| J9297 | Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg |
| J9298 | Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg |
| J9299 | Injection, nivolumab, 1 mg |
| J9300 | Injection, gemtuzumab ozogamicin, 5 mg |
| J9301 | Injection, obinutuzumab, 10 mg |
| J9302 | Injection, ofatumumab, 10 mg |
| J9303 | Injection, panitumumab, 10 mg |
| J9304 | Injection, pemetrexed (pemfexy), 10 mg |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg |
| J9306 | Injection, pertuzumab, 1 mg |
| J9307 | Injection, pralatrexate, 1 mg |
| J9308 | Injection, ramucirumab, 5 mg |
| J9309 | Injection, polatuzumab vedotin-piiq, 1 mg |
| J9310 | Injection, rituximab, 100 mg |
| J9311 | Injection, rituximab 10 mg and hyaluronidase |
| J9312 | Injection, rituximab, 10 mg |
| J9313 | Injection, moxetumomab pasudotox-tdfk, 0.01 mg |
| J9314 | Injection, pemetrexed (teva) not therapeutically equivalent to j9305, 10 mg |
| J9315 | Injection, romidepsin, 1 mg |
| J9316 | Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg |
| J9317 | Injection, sacituzumab govitecan-hziy, 2.5 mg |
| J9318 | Injection, romidepsin, non-lyophilized, 0.1 mg |
| J9319 | Injection, romidepsin, lyophilized, 0.1 mg |
| J9320 | Injection, streptozocin, 1 gram |
| J9322 | Injection, pemetrexed (bluepoint) not therapeutically equivalent to j9305, 10 mg |
| J9323 | Injection, pemetrexed ditromethamine, 10 mg |
| J9325 | Injection, talimogene laherparepvec, per 1 million plaque forming units |
| J9328 | Injection, temozolomide, 1 mg |
| J9330 | Injection, temsirolimus, 1 mg |
| J9331 | Injection, sirolimus protein-bound particles, 1 mg |
| J9332 | Injection, efgartigimod alfa-fcab, 2mg |
| J9340 | Injection, thiotepa, 15 mg |
| J9347 | Injection, tremelimumab-actl, 1 mg |
| J9348 | Injection, naxitamab-gqgk, 1 mg |
| J9349 | Injection, tafasitamab-cxix, 2 mg |
| J9350 | Injection, mosunetuzumab-axgb, 1 mg |
| J9351 | Injection, topotecan, 0.1 mg |
| J9352 | Injection, trabectedin, 0.1 mg |
| J9353 | Injection, margetuximab-cmkb, 5 mg |
| J9354 | Injection, ado-trastuzumab emtansine, 1 mg |
| J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg |
| J9356 | Injection, trastuzumab, 10 mg and hyaluronidase-oysk |
| J9357 | Injection, valrubicin, intravesical, 200 mg |
| J9358 | Injection, fam-trastuzumab deruxtecan-nxki, 1 mg |
| J9359 | Injection, loncastuximab tesirine-lpyl, 0.075 mg |
| J9360 | Injection, vinblastine sulfate, 1 mg |
| J9370 | Vincristine sulfate, 1 mg |
| J9371 | Injection, vincristine sulfate liposome, 1 mg |
| J9380 | Injection, teclistamab-cqyv, 0.5 mg |
| J9381 | Injection, teplizumab-mzwv, 5 mcg |
| J9390 | Injection, vinorelbine tartrate, 10 mg |
| J9393 | Injection, fulvestrant (teva) not therapeutically equivalent to j9395, 25 mg |
| J9394 | Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg |
| J9395 | Injection, fulvestrant, 25 mg |
| J9400 | Injection, ziv-aflibercept, 1 mg |
| J9600 | Injection, porfimer sodium, 75 mg |
| J9999 | Not otherwise classified, antineoplastic drugs |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg |
| J7513 | Daclizumab, parenteral, 25 mg |
| J7515 | Cyclosporine, oral, 25 mg |
| J7516 | Cyclosporin, parenteral, 250 mg |
| J7517 | Mycophenolate mofetil, oral, 250 mg |
| J7518 | Mycophenolic acid, oral, 180 mg |
| J7520 | Sirolimus, oral, 1 mg |
| J7525 | Tacrolimus, parenteral, 5 mg |
| J7527 | Everolimus, oral, 0.25 mg |
| J7599 | Immunosuppressive drug, not otherwise classified |
| J7604 | Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram |
| J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms |
| J7606 | Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms |
| J7607 | Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg |
| J7608 | Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
| J7612 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
| J7615 | Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
| J7622 | Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7624 | Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
| J7627 | Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg |
| J7628 | Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7629 | Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7631 | Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams |
| J7632 | Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams |
| J7633 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram |
| J7634 | Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram |
| J7635 | Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7636 | Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7637 | Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7638 | Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7639 | Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
| J7640 | Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms |
| J7641 | Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram |
| J7642 | Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7643 | Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
| J7645 | Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7647 | Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7648 | Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram |
| J7649 | Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
| J7650 | Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7657 | Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7658 | Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram |
| J7659 | Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
| J7660 | Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7665 | Mannitol, administered through an inhaler, 5 mg |
| J7667 | Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams |
| J7668 | Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams |
| J7669 | Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams |
| J7670 | Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams |
| J7674 | Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg |
| J7676 | Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg |
| J7677 | Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram |
| J7680 | Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7681 | Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7682 | Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams |
| J7683 | Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7684 | Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7685 | Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams |
| J7686 | Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg |
| J7699 | Noc drugs, inhalation solution administered through dme |
| J7799 | Noc drugs, other than inhalation drugs, administered through dme |
| J7999 | Compounded drug, not otherwise classified |
| J8498 | Antiemetic drug, rectal/suppository, not otherwise specified |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos |
| J8501 | Aprepitant, oral, 5 mg |
| J8510 | Busulfan; oral, 2 mg |
| J8515 | Cabergoline, oral, 0.25 mg |
| J8520 | Capecitabine, oral, 150 mg |
| J8521 | Capecitabine, oral, 500 mg |
| J8530 | Cyclophosphamide; oral, 25 mg |
| J8540 | Dexamethasone, oral, 0.25 mg |
| J8560 | Etoposide; oral, 50 mg |
| J8562 | Fludarabine phosphate, oral, 10 mg |
| J8565 | Gefitinib, oral, 250 mg |
| J8597 | Antiemetic drug, oral, not otherwise specified |
| J8600 | Melphalan; oral, 2 mg |
| J8610 | Methotrexate; oral, 2.5 mg |
| J8650 | Nabilone, oral, 1 mg |
| J8655 | Netupitant 300 mg and palonosetron 0.5 mg, oral |
| J8670 | Rolapitant, oral, 1 mg |
| J8700 | Temozolomide, oral, 5 mg |
| J8705 | Topotecan, oral, 0.25 mg |
| J8999 | Prescription drug, oral, chemotherapeutic, nos |
| J9000 | Injection, doxorubicin hydrochloride, 10 mg |
| J9010 | Injection, alemtuzumab, 10 mg |
| J9015 | Injection, aldesleukin, per single use vial |
| J9017 | Injection, arsenic trioxide, 1 mg |
| J9019 | Injection, asparaginase (erwinaze), 1,000 iu |
| J9020 | Injection, asparaginase, not otherwise specified, 10,000 units |
| J9021 | Injection, asparaginase, recombinant, (rylaze), 0.1 mg |
| J9022 | Injection, atezolizumab, 10 mg |
| J9023 | Injection, avelumab, 10 mg |
| J9025 | Injection, azacitidine, 1 mg |
| J9027 | Injection, clofarabine, 1 mg |
| J9029 | Injection, nadofaragene firadenovec-vncg, per therapeutic dose |
| J9030 | Bcg live intravesical instillation, 1 mg |
| J9031 | Bcg (intravesical) per instillation |
| J9032 | Injection, belinostat, 10 mg |
| J9033 | Injection, bendamustine hcl (treanda), 1 mg |
| J9034 | Injection, bendamustine hcl (bendeka), 1 mg |
| J9035 | Injection, bevacizumab, 10 mg |
| J9036 | Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg |
| J9037 | Injection, belantamab mafodotin-blmf, 0.5 mg |
| J9039 | Injection, blinatumomab, 1 microgram |
| J9040 | Injection, bleomycin sulfate, 15 units |
| J9041 | Injection, bortezomib, 0.1 mg |
| J9042 | Injection, brentuximab vedotin, 1 mg |
| J9043 | Injection, cabazitaxel, 1 mg |
| J9044 | Injection, bortezomib, not otherwise specified, 0.1 mg |
| J9045 | Injection, carboplatin, 50 mg |
| J9046 | Injection, bortezomib, (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg |
| J9047 | Injection, carfilzomib, 1 mg |
| J9048 | Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg |
| J9049 | Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg |
| J9050 | Injection, carmustine, 100 mg |
| J9055 | Injection, cetuximab, 10 mg |
| J9056 | Injection, bendamustine hydrochloride (vivimusta), 1 mg |
| J9057 | Injection, copanlisib, 1 mg |
| J9058 | Injection, bendamustine hydrochloride (apotex), 1 mg |
| J9059 | Injection, bendamustine hydrochloride (baxter), 1 mg |
| J9060 | Injection, cisplatin, powder or solution, 10 mg |
| J9061 | Injection, amivantamab-vmjw, 2 mg |
| J9063 | Injection, mirvetuximab soravtansine-gynx, 1 mg |
| J9065 | Injection, cladribine, per 1 mg |
| J9070 | Cyclophosphamide, 100 mg |
| J9071 | Injection, cyclophosphamide, (auromedics), 5 mg |
| J9098 | Injection, cytarabine liposome, 10 mg |
| J9100 | Injection, cytarabine, 100 mg |
| J9118 | Injection, calaspargase pegol-mknl, 10 units |
| J9119 | Injection, cemiplimab-rwlc, 1 mg |
| J9120 | Injection, dactinomycin, 0.5 mg |
| J9130 | Dacarbazine, 100 mg |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj |
| J9145 | Injection, daratumumab, 10 mg |
| J9150 | Injection, daunorubicin, 10 mg |
| J9151 | Injection, daunorubicin citrate, liposomal formulation, 10 mg |
| J9153 | Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine |
| J9155 | Injection, degarelix, 1 mg |
| J9160 | Injection, denileukin diftitox, 300 micrograms |
| J9165 | Injection, diethylstilbestrol diphosphate, 250 mg |
| J9171 | Injection, docetaxel, 1 mg |
| J9173 | Injection, durvalumab, 10 mg |
| J9175 | Injection, elliotts' b solution, 1 ml |
| J9176 | Injection, elotuzumab, 1 mg |
| J9177 | Injection, enfortumab vedotin-ejfv, 0.25 mg |
| J9178 | Injection, epirubicin hcl, 2 mg |
| J9179 | Injection, eribulin mesylate, 0.1 mg |
| J9181 | Injection, etoposide, 10 mg |
| J9185 | Injection, fludarabine phosphate, 50 mg |
| J9190 | Injection, fluorouracil, 500 mg |
| J9196 | Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg |
| J9198 | Injection, gemcitabine hydrochloride, (infugem), 100 mg |
| J9199 | Injection, gemcitabine hydrochloride (infugem), 200 mg |
| J9200 | Injection, floxuridine, 500 mg |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
| J9202 | Goserelin acetate implant, per 3.6 mg |
| J9203 | Injection, gemtuzumab ozogamicin, 0.1 mg |
| J9204 | Injection, mogamulizumab-kpkc, 1 mg |
| J9205 | Injection, irinotecan liposome, 1 mg |
| J9206 | Injection, irinotecan, 20 mg |
| J9207 | Injection, ixabepilone, 1 mg |
| J9208 | Injection, ifosfamide, 1 gram |
| J9209 | Injection, mesna, 200 mg |
| J9210 | Injection, emapalumab-lzsg, 1 mg |
| J9211 | Injection, idarubicin hydrochloride, 5 mg |
| J9212 | Injection, interferon alfacon-1, recombinant, 1 microgram |
| J9213 | Injection, interferon, alfa-2a, recombinant, 3 million units |
| J9214 | Injection, interferon, alfa-2b, recombinant, 1 million units |
| J9215 | Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu |
| J9216 | Injection, interferon, gamma 1-b, 3 million units |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg |
| J9218 | Leuprolide acetate, per 1 mg |
| J9219 | Leuprolide acetate implant, 65 mg |
| J9223 | Injection, lurbinectedin, 0.1 mg |
| J9225 | Histrelin implant (vantas), 50 mg |
| J9226 | Histrelin implant (supprelin la), 50 mg |
| J9227 | Injection, isatuximab-irfc, 10 mg |
| J9228 | Injection, ipilimumab, 1 mg |
| J9229 | Injection, inotuzumab ozogamicin, 0.1 mg |
| J9230 | Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg |
| J9245 | Injection, melphalan hydrochloride, not otherwise specified, 50 mg |
| J9246 | Injection, melphalan (evomela), 1 mg |
| J9247 | Injection, melphalan flufenamide, 1mg |
| J9250 | Methotrexate sodium, 5 mg |
| J9259 | Injection, paclitaxel protein-bound particles (american regent) not therapeutically equivalent to j9264, 1 mg |
| J9260 | Methotrexate sodium, 50 mg |
| J9261 | Injection, nelarabine, 50 mg |
| J9262 | Injection, omacetaxine mepesuccinate, 0.01 mg |
| J9263 | Injection, oxaliplatin, 0.5 mg |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg |
| J9265 | Injection, paclitaxel, 30 mg |
| J9266 | Injection, pegaspargase, per single dose vial |
| J9267 | Injection, paclitaxel, 1 mg |
| J9268 | Injection, pentostatin, 10 mg |
| J9269 | Injection, tagraxofusp-erzs, 10 micrograms |
| J9270 | Injection, plicamycin, 2.5 mg |
| J9271 | Injection, pembrolizumab, 1 mg |
| J9272 | Injection, dostarlimab-gxly, 10 mg |
| J9273 | Injection, tisotumab vedotin-tftv, 1 mg |
| J9274 | Injection, tebentafusp-tebn, 1 microgram |
| J9280 | Injection, mitomycin, 5 mg |
| J9281 | Mitomycin pyelocalyceal instillation, 1 mg |
| J9285 | Injection, olaratumab, 10 mg |
| J2793 | Injection, rilonacept, 1 mg |
| J2794 | Injection, risperidone (risperdal consta), 0.5 mg |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg |
| J2796 | Injection, romiplostim, 10 micrograms |
| J2797 | Injection, rolapitant, 0.5 mg |
| J2798 | Injection, risperidone, (perseris), 0.5 mg |
| J2800 | Injection, methocarbamol, up to 10 ml |
| J2805 | Injection, sincalide, 5 micrograms |
| J2806 | Injection, sincalide (maia) not therapeutically equivalent to j2805, 5 micrograms |
| J2810 | Injection, theophylline, per 40 mg |
| J2820 | Injection, sargramostim (gm-csf), 50 mcg |
| J2840 | Injection, sebelipase alfa, 1 mg |
| J2850 | Injection, secretin, synthetic, human, 1 microgram |
| J2860 | Injection, siltuximab, 10 mg |
| J2910 | Injection, aurothioglucose, up to 50 mg |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg |
| J2940 | Injection, somatrem, 1 mg |
| J2941 | Injection, somatropin, 1 mg |
| J2950 | Injection, promazine hcl, up to 25 mg |
| J2993 | Injection, reteplase, 18.1 mg |
| J2995 | Injection, streptokinase, per 250,000 iu |
| J2997 | Injection, alteplase recombinant, 1 mg |
| J2998 | Injection, plasminogen, human-tvmh, 1 mg |
| J3000 | Injection, streptomycin, up to 1 gm |
| J3010 | Injection, fentanyl citrate, 0.1 mg |
| J3030 | Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| J3031 | Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered) |
| J3032 | Injection, eptinezumab-jjmr, 1 mg |
| J3060 | Injection, taliglucerase alfa, 10 units |
| J3070 | Injection, pentazocine, 30 mg |
| J3090 | Injection, tedizolid phosphate, 1 mg |
| J3095 | Injection, telavancin, 10 mg |
| J3101 | Injection, tenecteplase, 1 mg |
| J3105 | Injection, terbutaline sulfate, up to 1 mg |
| J3110 | Injection, teriparatide, 10 mcg |
| J3111 | Injection, romosozumab-aqqg, 1 mg |
| J3120 | Injection, testosterone enanthate, up to 100 mg |
| J3121 | Injection, testosterone enanthate, 1 mg |
| J3130 | Injection, testosterone enanthate, up to 200 mg |
| J3140 | Injection, testosterone suspension, up to 50 mg |
| J3145 | Injection, testosterone undecanoate, 1 mg |
| J3150 | Injection, testosterone propionate, up to 100 mg |
| J3230 | Injection, chlorpromazine hcl, up to 50 mg |
| J3240 | Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial |
| J3241 | Injection, teprotumumab-trbw, 10 mg |
| J3243 | Injection, tigecycline, 1 mg |
| J3244 | Injection, tigecycline (accord) not therapeutically equivalent to j3243, 1 mg |
| J3245 | Injection, tildrakizumab, 1 mg |
| J3246 | Injection, tirofiban hcl, 0.25 mg |
| J3250 | Injection, trimethobenzamide hcl, up to 200 mg |
| J3260 | Injection, tobramycin sulfate, up to 80 mg |
| J3262 | Injection, tocilizumab, 1 mg |
| J3265 | Injection, torsemide, 10 mg/ml |
| J3280 | Injection, thiethylperazine maleate, up to 10 mg |
| J3285 | Injection, treprostinil, 1 mg |
| J3299 | Injection, triamcinolone acetonide (xipere), 1 mg |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
| J3302 | Injection, triamcinolone diacetate, per 5 mg |
| J3303 | Injection, triamcinolone hexacetonide, per 5 mg |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg |
| J3305 | Injection, trimetrexate glucuronate, per 25 mg |
| J3310 | Injection, perphenazine, up to 5 mg |
| J3315 | Injection, triptorelin pamoate, 3.75 mg |
| J3316 | Injection, triptorelin, extended-release, 3.75 mg |
| J3320 | Injection, spectinomycin dihydrochloride, up to 2 gm |
| J3350 | Injection, urea, up to 40 gm |
| J3355 | Injection, urofollitropin, 75 iu |
| J3357 | Ustekinumab, for subcutaneous injection, 1 mg |
| J3358 | Ustekinumab, for intravenous injection, 1 mg |
| J3360 | Injection, diazepam, up to 5 mg |
| J3364 | Injection, urokinase, 5000 iu vial |
| J3365 | Injection, iv, urokinase, 250,000 i.u. vial |
| J3370 | Injection, vancomycin hcl, 500 mg |
| J3371 | Injection, vancomycin hcl (mylan) not therapeutically equivalent to j3370, 500 mg |
| J3372 | Injection, vancomycin hcl (xellia) not therapeutically equivalent to j3370, 500 mg |
| J3380 | Injection, vedolizumab, 1 mg |
| J3385 | Injection, velaglucerase alfa, 100 units |
| J3396 | Injection, verteporfin, 0.1 mg |
| J3397 | Injection, vestronidase alfa-vjbk, 1 mg |
| J3398 | Injection, voretigene neparvovec-rzyl, 1 billion vector genomes |
| J3399 | Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes |
| J3400 | Injection, triflupromazine hcl, up to 20 mg |
| J3410 | Injection, hydroxyzine hcl, up to 25 mg |
| J3411 | Injection, thiamine hcl, 100 mg |
| J3415 | Injection, pyridoxine hcl, 100 mg |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
| J3430 | Injection, phytonadione (vitamin k), per 1 mg |
| J3465 | Injection, voriconazole, 10 mg |
| J3470 | Injection, hyaluronidase, up to 150 units |
| J3471 | Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) |
| J3472 | Injection, hyaluronidase, ovine, preservative free, per 1000 usp units |
| J3473 | Injection, hyaluronidase, recombinant, 1 usp unit |
| J3475 | Injection, magnesium sulfate, per 500 mg |
| J3480 | Injection, potassium chloride, per 2 meq |
| J3485 | Injection, zidovudine, 10 mg |
| J3486 | Injection, ziprasidone mesylate, 10 mg |
| J3489 | Injection, zoledronic acid, 1 mg |
| J3490 | Unclassified drugs |
| J3520 | Edetate disodium, per 150 mg |
| J3530 | Nasal vaccine inhalation |
| J3535 | Drug administered through a metered dose inhaler |
| J3570 | Laetrile, amygdalin, vitamin b17 |
| J3590 | Unclassified biologics |
| J3591 | Unclassified drug or biological used for esrd on dialysis |
| J7030 | Infusion, normal saline solution , 1000 cc |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) |
| J7050 | Infusion, normal saline solution, 250 cc |
| J7060 | 5% dextrose/water (500 ml = 1 unit) |
| J7070 | Infusion, d5w, 1000 cc |
| J7100 | Infusion, dextran 40, 500 ml |
| J7110 | Infusion, dextran 75, 500 ml |
| J7120 | Ringers lactate infusion, up to 1000 cc |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc |
| J7131 | Hypertonic saline solution, 1 ml |
| J7168 | Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity |
| J7169 | Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg |
| J7170 | Injection, emicizumab-kxwh, 0.5 mg |
| J7175 | Injection, factor x, (human), 1 i.u. |
| J7177 | Injection, human fibrinogen concentrate (fibryga), 1 mg |
| J7178 | Injection, human fibrinogen concentrate, not otherwise specified, 1 mg |
| J7179 | Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco |
